Trial
NCT02027298
Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
The Cleveland Clinic
Collaborators
Bristol-Myers Squibb
Condition
Primary Sjogren's Syndrome
Intervention
Abatacept
Why stopped
No Enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-01-09